Jeff Bezos, the illustrious founder of Amazon and a distinguished billionaire entrepreneur, has strategically channeled his investments into the realm of healthcare and biotech. Notably, he directed his resources towards companies like Juno Therapeutics, which, subsequent to his investment, merged with Bristol Myers Squibb. This strategic investment underscores his engagement in advancing cancer vaccine development and highlights his profound interest in cutting-edge solutions within the biotech sector.